Bridgeway Capital Management’s General Moly, Inc. GMO Stock Holding History

Bridgeway Capital Management’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-542,000	Closed	-$61K	–	1403
2020 Q3	$61K	Hold	542,000	–	–	﹤0.01%	1290
2020 Q2	$109K	Buy	+542,000	New	+$107K	﹤0.01%	1223
2014 Q2	–	Sell	-200,000	Closed	-$198K	–	1474
2014 Q1	$198K	Buy	+200,000	New	+$243K	0.01%	1324

Other funds holding GMO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Bridgeway Capital Management's GMO Position: Q4 2020 in Review

Bridgeway Capital Management sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 542,000 shares — an estimated $61K sold.

Bridgeway Capital Management first reported a position in GMO in Q1 2014 and held it in 3 quarters. The position peaked at $198K in Q1 2014. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.

Bridgeway Capital Management reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
Bridgeway Capital Management sold 542,000 General Moly, Inc. shares in Q4 2020, an estimated $61K.
Bridgeway Capital Management first reported a position in General Moly, Inc. in Q1 2014 and held it in 3 quarters.
Bridgeway Capital Management's General Moly, Inc. position peaked at $198K in Q1 2014.
7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.